Indian Medtech Breakthrough: Meril Life Sciences Shines At PCR London Valves 2025

India’s MedTech sector achieved a milestone moment at PCR London Valves 2025, one of the world’s most prestigious conferences on structural heart interventions. Meril Life Sciences presented pivotal one-year results from the LANDMARK Randomized Controlled Trial (RCT), the first-ever multicenter RCT to evaluate an Indian-developed THV against leading international platforms.  

The Myval THV series, a balloon-expandable transcatheter heart valve developed indigenously, demonstrated comparable efficacy to established global systems. This achievement underscores India’s rising influence in cardiovascular innovation and highlights the country’s ability to deliver world-class medical technology solutions.  

Key highlights from the announcement include  

• Meril Life Sciences presented one-year outcomes of the LANDMARK RCT at PCR London Valves 2025.  
• The trial compared India’s Myval THV series with Edwards Lifesciences and Medtronic platforms.  
• It is the first multicenter RCT evaluating an Indian-developed THV against global leaders.  
• Myval THV demonstrated comparable composite clinical efficacy, including freedom from all-cause mortality and major adverse events.  
• The results enhance India’s credibility in global cardiovascular device innovation.  
• Meril’s achievement reflects the growing strength of India’s MedTech ecosystem.  
• The presentation was part of the Late-Breaking Trial sessions, highlighting its global significance.  
• The development positions India as a reliable contributor to structural heart solutions worldwide.  
• The trial outcomes are expected to boost confidence among clinicians and regulators in adopting Indian-developed THVs.  
• Meril Life Sciences continues to expand its footprint in advanced cardiovascular technologies.  

This breakthrough not only elevates Meril Life Sciences but also signals India’s emergence as a serious player in the global MedTech arena. By competing head-to-head with established international giants, India’s innovation story is gaining recognition, paving the way for greater adoption of indigenous medical technologies worldwide.  

Sources: Business Standard, ANI News, Devdiscourse